Sign in
4

Changes in Ownership

Vivos Therapeutics, Inc. Filed Acc 0001493152-21-019258

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Thompson Matthew Director 2021-08-05 Grant or award · Stock Option (Right to Buy) +30,000 $2.72 $81,600 46,667 D
Loading xslF345X03/ownership.xml…